[1]
“The Effect of In-Hospital Intervention to Reduce Door to Needle Time in Patients Receiving Tissue Plasminogen Activator”, J. Intellect. Disabl. Diagn. Treat., vol. 8, no. 2, pp. 112–116, May 2020, doi: 10.6000/2292-2598.2020.08.02.4.